Nuclear Translocation Uncovers the Amyloid Peptide Aβ42 as a Regulator of Gene Transcription*
Open Access
- 1 July 2014
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (29) , 20182-20191
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Novel APP/Aβ mutation K16N produces highly toxic heteromeric Aβ oligomersEMBO Molecular Medicine, 2012
- Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesisGene, 2011
- The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: Characterizing a new regulatory motifGene, 2011
- The cellular prion protein mediates neurotoxic signalling of β‐sheet‐rich conformers independent of prion replicationThe EMBO Journal, 2011
- Characterisation of the passive permeability barrier of nuclear pore complexesThe EMBO Journal, 2009
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomersNature, 2009
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1Neuron, 2007
- Intraneuronal Aβ immunoreactivity is not a predictor of brain amyloidosis-β or neurofibrillary degenerationActa Neuropathologica, 2007